2015 Oct 28. pii: S1043-6618(15)00258-3. doi: 10.1016/j.phrs.2015.10.015. [Epub ahead of print]
Zádor F1, Wollemann M2.
Abstract
A growing amount of data demonstrates the interactions between cannabinoid, opioid and the transient receptor potential (TRP) vanilloid type 1 (TRPV1) receptors. These interactions can be bidirectional, inhibitory or excitatory, acute or chronic in their nature, and arise both at the molecular level (structurally and functionally) and in physiological processes, such as pain modulation or perception. The interactions of these three pain-related receptors may also reserve important and new therapeutic applications for the treatment of chronic pain or inflammation. In this review we summarize the main findings on the interactions between the cannabinoid, opioid and the TRPV1 receptor regarding to pain modulation.
Copyright © 2015. Published by Elsevier Ltd.
Copyright © 2015. Published by Elsevier Ltd.
KEYWORDS:
TRPV1 receptor; cannabinoid receptor; opioid receptor; pain; receptor interaction
- PMID:
- 26520391
- [PubMed – as supplied by publisher]
-
Publication Types